The 12th Annual China Healthcare Investment Conference held its Awards Gala in Shanghai, recognizing achievements in healthcare investment, financing, and deal-making. Winners included Insilico Medicine, Kailera Therapeutics, Vor Bio, and partnerships between Hengrui-GSK and Innovent-Takeda.
Samsung Biologics completed acquisition of GSK's Rockville, Maryland biopharmaceutical production facility with 60,000L capacity, expanding total production to 845,000L and establishing first US manufacturing base.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.